Wenger Vieli Ltd is well-equipped to assist with mandates concerning the de-listing of reimbursed products, M&A, and product liability claims. Frank Scherrer leads the team with his longstanding expertise in establishment licences, marketing authorisations, and data protection issues. Marcel Boller is a key contact for pharma companies and pharmacies seeking advice on data exclusivity issues and joint ventures.
Legal 500 redaktioneller Kommentar
- Profil
Highlight-Mandate
Advising a global pharmaceutical company in relation to the introduction by the regulator of turnover based rebates.
Represented a pharmaceutical company in appeal proceedings regarding the deletion of one of its products from the list of reimbursed products.
Advised IK Partners on the EUR 370m sale of Klingel medical metal group to Elos Medtech.
Anwält*innen
Praxisleitung
Frank Scherrer
Weitere Kernanwält*innen
Marcel Boller